H
Humedica
Health · Boston, United States · Founded 1979
Real world data. Actionable insights. Confident decision-making. #Humedica, #clinicalanalytics, #populationhealth MoreLess
Founded in 2008, Humedica emerged as a trailblazer in the realm of clinical intelligence, providing cloud-based analytics solutions tailored for the healthcare industry. The company was the brainchild of Michael Weintraub, who envisioned a platform that could harness the power of data to improve healthcare outcomes.
Humedica's innovative approach involved assembling, standardizing, and analyzing electronic health records and financial data, offering healthcare providers actionable insights to enhance patient care. This unique value proposition quickly attracted attention, leading to significant investments from notable entities like Merck and Allscripts.
In a pivotal moment for the company, Humedica was acquired by UnitedHealth Group's Optum division in January 2013. The acquisition, reportedly valued at hundreds of millions of dollars, underscored the strategic importance of data analytics in healthcare and marked a significant milestone in Humedica's journey.
Through this acquisition, Humedica's capabilities were integrated into Optum's broader suite of healthcare services, amplifying its impact and reach. This move not only validated Humedica's business model but also highlighted the growing demand for sophisticated data solutions in the healthcare sector. Today, Humedica's legacy continues to influence the industry, setting a benchmark for clinical intelligence and data-driven healthcare solutions.
Company overview
Humedica company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 1979
- Headquarters
- Boston, United States
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 75.3
Valuation & funding
Humedica funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| FundingOther financing | Jun 2013 | $0 | — | Undisclosed | ↗ |
| ACQUISITIONOther financing | Jan 2013 | $0 | — | UnitedHealth Group | — |
| EARLY VCOther financing | Apr 2012 | $10M | $40M | Veradigm (Allscripts Healthcare Solutions) · West Health Investment Fund · Bain Capital Ventures · The Kraft Group | — |
| LATE VCOther financing | Oct 2011 | $23M | $92M | Undisclosed | — |
| SERIES AOther financing | Oct 2009 | $30M | $120M | Bain Capital Ventures | — |
Growth signals
Humedica website traffic
Latest recorded traffic for Humedica is 0 monthly website visits. Humedica's team grew 5.3% over the past year.
Comparisons
Humedica compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Humedica's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Humedica has talent and traffic
team presence
In the news
Latest news about Humedica
Recent press, funding announcements, and product moves mentioning Humedica — open to read from the original sources.
Market sentiment
What the market is saying about Humedica
An AI-synthesized read of the highest-engagement posts about Humedica on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Humedica’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.